Nurix Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Nurix Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Nurix Therapeutics, Inc. Operating Margin for the quarter ending February 29, 2024 was -195 %, a 55.9% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2023 was -201 %, a 57.7% increase from 2022.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2022 was -476 %, a 20.1% decline from 2021.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2021 was -396 %, a 8.66% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -201 +275 +57.7% Dec 1, 2022 Nov 30, 2023
2022 -476 -79.8 -20.1% Dec 1, 2021 Nov 30, 2022
2021 -396 -31.6 -8.66% Dec 1, 2020 Nov 30, 2021
2020 -365 -293 -410% Dec 1, 2019 Nov 30, 2020
2019 -71.5 Dec 1, 2018 Nov 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.